论文部分内容阅读
肺心病系中年以上劳动人民常见病,多发病,严重影响人民的健康。目前在治疗中还存在许多问题需要解决。本文仅就应用芬妥拉明 (Regitine)静脉滴注治疗肺心病对二氧化碳分压影响的观察作一初步报告。一、一般资料本组系1974年11月～1975年5月间,其中经芬妥拉明治疗的住院患者共25例。男性15例,女性10例。肺心病的原发病有:慢性气管炎肺气肿20例,支气管哮喘3例,肺结核胸改术后1例,先天性肺囊肿1例。
Pulmonary heart disease in middle-aged working people common disease, frequently-occurring disease, seriously affecting people’s health. At present there are still many problems to be solved in the treatment. This article only on the application of intravenous infusion of Regitine pulmonary heart disease on the impact of partial pressure of carbon dioxide to make a preliminary report. First, the general information of the Department of Department of November 1974 ~ May 1975, of which a total of 25 cases of patients treated with vetiverilide. 15 males and 10 females. Pulmonary heart disease are: 20 cases of chronic bronchitis emphysema, bronchial asthma in 3 cases, 1 case of tuberculosis after thoracotomy, congenital pulmonary cysts in 1 case.